The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Choroidal Neovascularization Market Research Report 2024
Synopsis
Choroidal neovascularization describes the growth of new blood vessels that originate from the choroid through a break in the Bruch membrane into the sub–retinal pigment epithelium (sub-RPE) or subretinal space.
The global Choroidal Neovascularization market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Choroidal Neovascularization, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Choroidal Neovascularization.
Report Scope
The Choroidal Neovascularization market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Choroidal Neovascularization market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Choroidal Neovascularization manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer Inc.
F. Hoffmann-La Roche Ltd.
Novartis AG
Regeneron Pharmaceuticals Inc.
Bayer AG
QLT Inc.
Sanwa Kagaku Kenkyusho Co. Ltd.
Promedior Inc.
Bausch Health
Gilead Sciences Inc
Segment by Type
Intravenous
Intravitreal
Segment by Application
Extreme Myopia
Malignant Myopic Degeneration
Age-Related Developments
Consumption by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Choroidal Neovascularization manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Choroidal Neovascularization in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Choroidal neovascularization describes the growth of new blood vessels that originate from the choroid through a break in the Bruch membrane into the sub–retinal pigment epithelium (sub-RPE) or subretinal space.
The global Choroidal Neovascularization market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Choroidal Neovascularization, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Choroidal Neovascularization.
Report Scope
The Choroidal Neovascularization market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Choroidal Neovascularization market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Choroidal Neovascularization manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer Inc.
F. Hoffmann-La Roche Ltd.
Novartis AG
Regeneron Pharmaceuticals Inc.
Bayer AG
QLT Inc.
Sanwa Kagaku Kenkyusho Co. Ltd.
Promedior Inc.
Bausch Health
Gilead Sciences Inc
Segment by Type
Intravenous
Intravitreal
Segment by Application
Extreme Myopia
Malignant Myopic Degeneration
Age-Related Developments
Consumption by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Choroidal Neovascularization manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Choroidal Neovascularization in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Choroidal Neovascularization Market Overview
1.1 Product Overview and Scope of Choroidal Neovascularization
1.2 Choroidal Neovascularization Segment by Type
1.2.1 Global Choroidal Neovascularization Market Value Comparison by Type (2024-2030)
1.2.2 Intravenous
1.2.3 Intravitreal
1.3 Choroidal Neovascularization Segment by Application
1.3.1 Global Choroidal Neovascularization Market Value by Application: (2024-2030)
1.3.2 Extreme Myopia
1.3.3 Malignant Myopic Degeneration
1.3.4 Age-Related Developments
1.4 Global Choroidal Neovascularization Market Size Estimates and Forecasts
1.4.1 Global Choroidal Neovascularization Revenue 2019-2030
1.4.2 Global Choroidal Neovascularization Sales 2019-2030
1.4.3 Global Choroidal Neovascularization Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Choroidal Neovascularization Market Competition by Manufacturers
2.1 Global Choroidal Neovascularization Sales Market Share by Manufacturers (2019-2024)
2.2 Global Choroidal Neovascularization Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Choroidal Neovascularization Average Price by Manufacturers (2019-2024)
2.4 Global Choroidal Neovascularization Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Choroidal Neovascularization, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Choroidal Neovascularization, Product Type & Application
2.7 Choroidal Neovascularization Market Competitive Situation and Trends
2.7.1 Choroidal Neovascularization Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Choroidal Neovascularization Players Market Share by Revenue
2.7.3 Global Choroidal Neovascularization Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Choroidal Neovascularization Retrospective Market Scenario by Region
3.1 Global Choroidal Neovascularization Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Choroidal Neovascularization Global Choroidal Neovascularization Sales by Region: 2019-2030
3.2.1 Global Choroidal Neovascularization Sales by Region: 2019-2024
3.2.2 Global Choroidal Neovascularization Sales by Region: 2025-2030
3.3 Global Choroidal Neovascularization Global Choroidal Neovascularization Revenue by Region: 2019-2030
3.3.1 Global Choroidal Neovascularization Revenue by Region: 2019-2024
3.3.2 Global Choroidal Neovascularization Revenue by Region: 2025-2030
3.4 North America Choroidal Neovascularization Market Facts & Figures by Country
3.4.1 North America Choroidal Neovascularization Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Choroidal Neovascularization Sales by Country (2019-2030)
3.4.3 North America Choroidal Neovascularization Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.4.6 Mexico
3.5 Europe Choroidal Neovascularization Market Facts & Figures by Country
3.5.1 Europe Choroidal Neovascularization Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Choroidal Neovascularization Sales by Country (2019-2030)
3.5.3 Europe Choroidal Neovascularization Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Choroidal Neovascularization Market Facts & Figures by Country
3.6.1 Asia Pacific Choroidal Neovascularization Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Choroidal Neovascularization Sales by Country (2019-2030)
3.6.3 Asia Pacific Choroidal Neovascularization Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Indonesia
3.6.10 Thailand
3.6.11 Malaysia
3.6.12 Philippines
3.6.13 Vietnam
3.7 Latin America Choroidal Neovascularization Market Facts & Figures by Country
3.7.1 Latin America Choroidal Neovascularization Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Choroidal Neovascularization Sales by Country (2019-2030)
3.7.3 Latin America Choroidal Neovascularization Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Choroidal Neovascularization Market Facts & Figures by Country
3.8.1 Middle East and Africa Choroidal Neovascularization Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Choroidal Neovascularization Sales by Country (2019-2030)
3.8.3 Middle East and Africa Choroidal Neovascularization Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Choroidal Neovascularization Sales by Type (2019-2030)
4.1.1 Global Choroidal Neovascularization Sales by Type (2019-2024)
4.1.2 Global Choroidal Neovascularization Sales by Type (2025-2030)
4.1.3 Global Choroidal Neovascularization Sales Market Share by Type (2019-2030)
4.2 Global Choroidal Neovascularization Revenue by Type (2019-2030)
4.2.1 Global Choroidal Neovascularization Revenue by Type (2019-2024)
4.2.2 Global Choroidal Neovascularization Revenue by Type (2025-2030)
4.2.3 Global Choroidal Neovascularization Revenue Market Share by Type (2019-2030)
4.3 Global Choroidal Neovascularization Price by Type (2019-2030)
5 Segment by Application
5.1 Global Choroidal Neovascularization Sales by Application (2019-2030)
5.1.1 Global Choroidal Neovascularization Sales by Application (2019-2024)
5.1.2 Global Choroidal Neovascularization Sales by Application (2025-2030)
5.1.3 Global Choroidal Neovascularization Sales Market Share by Application (2019-2030)
5.2 Global Choroidal Neovascularization Revenue by Application (2019-2030)
5.2.1 Global Choroidal Neovascularization Revenue by Application (2019-2024)
5.2.2 Global Choroidal Neovascularization Revenue by Application (2025-2030)
5.2.3 Global Choroidal Neovascularization Revenue Market Share by Application (2019-2030)
5.3 Global Choroidal Neovascularization Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer Inc.
6.1.1 Pfizer Inc. Corporation Information
6.1.2 Pfizer Inc. Description and Business Overview
6.1.3 Pfizer Inc. Choroidal Neovascularization Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Inc. Choroidal Neovascularization Product Portfolio
6.1.5 Pfizer Inc. Recent Developments/Updates
6.2 F. Hoffmann-La Roche Ltd.
6.2.1 F. Hoffmann-La Roche Ltd. Corporation Information
6.2.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
6.2.3 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Sales, Revenue and Gross Margin (2019-2024)
6.2.4 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Product Portfolio
6.2.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
6.3 Novartis AG
6.3.1 Novartis AG Corporation Information
6.3.2 Novartis AG Description and Business Overview
6.3.3 Novartis AG Choroidal Neovascularization Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novartis AG Choroidal Neovascularization Product Portfolio
6.3.5 Novartis AG Recent Developments/Updates
6.4 Regeneron Pharmaceuticals Inc.
6.4.1 Regeneron Pharmaceuticals Inc. Corporation Information
6.4.2 Regeneron Pharmaceuticals Inc. Description and Business Overview
6.4.3 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Product Portfolio
6.4.5 Regeneron Pharmaceuticals Inc. Recent Developments/Updates
6.5 Bayer AG
6.5.1 Bayer AG Corporation Information
6.5.2 Bayer AG Description and Business Overview
6.5.3 Bayer AG Choroidal Neovascularization Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bayer AG Choroidal Neovascularization Product Portfolio
6.5.5 Bayer AG Recent Developments/Updates
6.6 QLT Inc.
6.6.1 QLT Inc. Corporation Information
6.6.2 QLT Inc. Description and Business Overview
6.6.3 QLT Inc. Choroidal Neovascularization Sales, Revenue and Gross Margin (2019-2024)
6.6.4 QLT Inc. Choroidal Neovascularization Product Portfolio
6.6.5 QLT Inc. Recent Developments/Updates
6.7 Sanwa Kagaku Kenkyusho Co. Ltd.
6.6.1 Sanwa Kagaku Kenkyusho Co. Ltd. Corporation Information
6.6.2 Sanwa Kagaku Kenkyusho Co. Ltd. Description and Business Overview
6.6.3 Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Product Portfolio
6.7.5 Sanwa Kagaku Kenkyusho Co. Ltd. Recent Developments/Updates
6.8 Promedior Inc.
6.8.1 Promedior Inc. Corporation Information
6.8.2 Promedior Inc. Description and Business Overview
6.8.3 Promedior Inc. Choroidal Neovascularization Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Promedior Inc. Choroidal Neovascularization Product Portfolio
6.8.5 Promedior Inc. Recent Developments/Updates
6.9 Bausch Health
6.9.1 Bausch Health Corporation Information
6.9.2 Bausch Health Description and Business Overview
6.9.3 Bausch Health Choroidal Neovascularization Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Bausch Health Choroidal Neovascularization Product Portfolio
6.9.5 Bausch Health Recent Developments/Updates
6.10 Gilead Sciences Inc
6.10.1 Gilead Sciences Inc Corporation Information
6.10.2 Gilead Sciences Inc Description and Business Overview
6.10.3 Gilead Sciences Inc Choroidal Neovascularization Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Gilead Sciences Inc Choroidal Neovascularization Product Portfolio
6.10.5 Gilead Sciences Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Choroidal Neovascularization Industry Chain Analysis
7.2 Choroidal Neovascularization Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Choroidal Neovascularization Production Mode & Process
7.4 Choroidal Neovascularization Sales and Marketing
7.4.1 Choroidal Neovascularization Sales Channels
7.4.2 Choroidal Neovascularization Distributors
7.5 Choroidal Neovascularization Customers
8 Choroidal Neovascularization Market Dynamics
8.1 Choroidal Neovascularization Industry Trends
8.2 Choroidal Neovascularization Market Drivers
8.3 Choroidal Neovascularization Market Challenges
8.4 Choroidal Neovascularization Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
